We have located links that may give you full text access.
Edema Fluid Can Be Successfully Evacuated from the Lymphedematous Limbs by Implantation of Silicone Tubings Bypassing the Site of Flow Obstruction Long-Term Observations.
Lymphatic Research and Biology 2019 Februrary 28
BACKGROUND: Lymphedema of limbs is caused by partial or total obstruction of lymphatic collectors. In advanced cases all main lymphatics are obstructed and tissue fluid accumulates in the interstitial spaces. The microsurgical lympho-venous shunts cannot be performed. We propose in such cases drainage of fluid accumulations by creating artificial flow pathways to the nonobstructed regions by implantation of silicone tubes.
AIM: To present the 3 to over 6 year follow-up results of therapy by subcutaneous implantation of silicone tubes.
METHODS: In 150 patients with obstructive limb lymphedema after pelvic or axillary lymphadenectomy and irradiation in uterine or breast cancer or following soft tissue inflammation silicone tubes were implanted subcutaneously.
RESULTS: There was (1) immediate decrease of limb circumference within days after implantation; (2) in lower limbs in a 3-year follow-up a decrease in mid-calf circumference by a mean -8.7% (p < 0.05) with range of -3.2% to -31.0% corresponding to 90-900 mL volume and in the mid-thigh a mean -1.8% (p < 0.05) with range of -9.3% to +3% equal to 0-900 mL. In the upper limb in the 2-year follow-up the decrease in the mid-forearm was -8.5% (p < 0.01) with a range of -3.0% to -22.0% and in the mid-arm a mean -12% (p < 0.05) with a range of -7% to -22%. That corresponded to 180-700 mL volume for the limb; (3) decreased tissue stiffness; (4) maintenance of tubes patency on control lymphoscintigraphy, contrast opacification, and ultrasonography; and (5) lack of reaction to foreign body and effective control of inflammation at the site of implantation using low doses of benzathine penicillin.
CONCLUSIONS: The technical simplicity of the surgical procedure, fast decrease of limb edema, and lack of tissue reaction to the implant make the method worth applying in advanced stages of lymphedema.
AIM: To present the 3 to over 6 year follow-up results of therapy by subcutaneous implantation of silicone tubes.
METHODS: In 150 patients with obstructive limb lymphedema after pelvic or axillary lymphadenectomy and irradiation in uterine or breast cancer or following soft tissue inflammation silicone tubes were implanted subcutaneously.
RESULTS: There was (1) immediate decrease of limb circumference within days after implantation; (2) in lower limbs in a 3-year follow-up a decrease in mid-calf circumference by a mean -8.7% (p < 0.05) with range of -3.2% to -31.0% corresponding to 90-900 mL volume and in the mid-thigh a mean -1.8% (p < 0.05) with range of -9.3% to +3% equal to 0-900 mL. In the upper limb in the 2-year follow-up the decrease in the mid-forearm was -8.5% (p < 0.01) with a range of -3.0% to -22.0% and in the mid-arm a mean -12% (p < 0.05) with a range of -7% to -22%. That corresponded to 180-700 mL volume for the limb; (3) decreased tissue stiffness; (4) maintenance of tubes patency on control lymphoscintigraphy, contrast opacification, and ultrasonography; and (5) lack of reaction to foreign body and effective control of inflammation at the site of implantation using low doses of benzathine penicillin.
CONCLUSIONS: The technical simplicity of the surgical procedure, fast decrease of limb edema, and lack of tissue reaction to the implant make the method worth applying in advanced stages of lymphedema.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app